| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/1998 | EP0833907A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 04/08/1998 | EP0833906A2 Novel ctla4/cd28 ligands and uses therefor |
| 04/08/1998 | EP0833899A1 Cis-9,10-octadecenoamidase |
| 04/08/1998 | EP0833844A1 SINGLE CHAIN ANALOGS OF THE TGF-$g(b) SUPERFAMILY (MORPHONS) |
| 04/08/1998 | EP0833837A1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
| 04/08/1998 | EP0833828A1 Rapamycin derivatives |
| 04/08/1998 | EP0833826A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 04/08/1998 | EP0833825A1 6-carboxamido dihydropyran derivatives |
| 04/08/1998 | EP0833824A2 Small molecule inhibition of rna/ligand binding |
| 04/08/1998 | EP0833823A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands |
| 04/08/1998 | EP0833822A1 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 04/08/1998 | EP0833820A1 Benzisoxazole and indazole derivatives as antipsychotic agents |
| 04/08/1998 | EP0833819A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides |
| 04/08/1998 | EP0833818A1 Cb 2? receptor agonist compounds |
| 04/08/1998 | EP0833671A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 04/08/1998 | EP0833667A1 Stabilization of polynucleotide complexes |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833658A1 Inhibin compositions and methods of enhancing production performance |
| 04/08/1998 | EP0833652A1 Novel kappa receptor selective opioid peptides |
| 04/08/1998 | EP0833651A1 ANALGESIC USE OF N-L-$g(a)-ASPARTYL-L-PHENYLALANINE 1-METHYL ESTER |
| 04/08/1998 | EP0833649A1 Methods of preventing or treating allergies |
| 04/08/1998 | EP0833645A1 Antiviral agents |
| 04/08/1998 | EP0833644A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 04/08/1998 | EP0833643A1 Anhydrous alendronate monosodium salt formulations |
| 04/08/1998 | EP0833642A1 Compressed dry-granulation desogestrel tablets |
| 04/08/1998 | EP0833641A1 Treatment and prevention of prostatic disease |
| 04/08/1998 | EP0833640A1 Pharmaceutical composition containing lamotrigine |
| 04/08/1998 | EP0833639A1 Phenoxy piperazine derivatives for treating disorders of the dopamine system |
| 04/08/1998 | EP0833638A1 USE OF IMIDAZO 1,5-a]QUINOLONES AS NEUROPROTECTIVE AGENTS |
| 04/08/1998 | EP0833637A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST |
| 04/08/1998 | EP0833636A1 Method for inhibiting neoplastic disease in mammals |
| 04/08/1998 | EP0833635A1 Novel use for pyrrole derivatives |
| 04/08/1998 | EP0833634A1 Use of n-cyclohexyl benzamides for treating bowel disorders |
| 04/08/1998 | EP0833632A1 Method to increase retinal blood flow |
| 04/08/1998 | EP0833631A1 Biflavanoids and derivatives thereof as antiviral agents |
| 04/08/1998 | EP0833630A1 Novel benzopyran compounds and methods for their use |
| 04/08/1998 | EP0833629A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/08/1998 | EP0833628A1 Novel taxoids |
| 04/08/1998 | EP0833627A2 Iron compounds, compositions, methods of making the same and uses thereof |
| 04/08/1998 | EP0833626A1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 04/08/1998 | EP0833625A1 Method for regulating glucose metabolism |
| 04/08/1998 | EP0833624A2 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 04/08/1998 | EP0833623A1 Method for treating multiple sclerosis |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/08/1998 | EP0833619A1 Controlled release of drugs delivered by sublingual or buccal administration |
| 04/08/1998 | EP0833613A1 Delivery vehicles comprising stable lipid/nucleic acid complexes |
| 04/08/1998 | EP0833612A1 New pharmaceutical composition with anaesthetic effect |
| 04/08/1998 | EP0833611A1 A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 04/08/1998 | EP0833606A1 Stable hydroalcoholic compositions |
| 04/08/1998 | EP0833605A1 Stable hydroalcoholic compositions |
| 04/08/1998 | EP0833573A1 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals |
| 04/08/1998 | EP0833568A1 Use of hydroxy acid or a product containing the same and a product made thereof |
| 04/08/1998 | EP0715624B1 Process for the preparation of benzodiazepine compounds useful as antagonists of cck or of gastrine |
| 04/08/1998 | EP0706512B1 Acetamide derivatives and their use for modifying feeding behaviour modifiers |
| 04/08/1998 | EP0703731B1 Food and/or pharmaceutical composition having a low polyamine content, and therapeutical uses thereof |
| 04/08/1998 | EP0702679B1 Process for the isolation of lovastatin |
| 04/08/1998 | EP0688313B1 Ligands and metal complexes thereof |
| 04/08/1998 | EP0680488B1 2,6-diaminopurine derivatives |
| 04/08/1998 | EP0667852B1 Novel 3,3-diphenylpropylamines, their use and preparation |
| 04/08/1998 | EP0623021B1 4''-deoxyerythromycin derivatives |
| 04/08/1998 | EP0562006B1 Homo-prostaglandin derivatives as ocular hypotensives |
| 04/08/1998 | EP0558681B1 Treatment for tissue ulceration |
| 04/08/1998 | EP0558630B1 Retroviral protease inhibitors |
| 04/08/1998 | EP0439508B1 Polyethylene glycolcol (peg)-protein adducts and process for their fractionation |
| 04/08/1998 | CN1178536A 17 -difluoromethylene-oesteratrienes |
| 04/08/1998 | CN1178535A Therapeutic compound-fatty acid conjugates |
| 04/08/1998 | CN1178533A Process for isolating galanthamine |
| 04/08/1998 | CN1178532A Tricyclic vasopressin antagonists |
| 04/08/1998 | CN1178529A Heterocyclic subsitituted piperazinone derivatives as tachykinin receptor antagonists |
| 04/08/1998 | CN1178528A 10 -deacetylbaccatine III and 10 -deacetyl 14 'beta' -hydroxybaccatine III derivatives, process for preparation thereof and pharmaceutical compositions containing them |
| 04/08/1998 | CN1178525A Substituted phenyl compounds as endothelin antagonists |
| 04/08/1998 | CN1178524A Di-substituted 1, 4 -piperidine esters and amides having 5-HT4 antagonistic activity |
| 04/08/1998 | CN1178523A Aminophenol derivatives |
| 04/08/1998 | CN1178521A Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 04/08/1998 | CN1178467A Polyphenol fractions of tea, the use thereof and formulations containing same |
| 04/08/1998 | CN1178466A Antitumor agents comprising as the principal agent compounds |
| 04/08/1998 | CN1178465A Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premeno pausal women |
| 04/08/1998 | CN1178464A Benzothiophene pharmaceutical compounds |
| 04/08/1998 | CN1178463A Use of anti-oestrogens as male contraceptives |
| 04/08/1998 | CN1178462A Methods and pharmaceutical compostions employing desmethylselegiline |
| 04/08/1998 | CN1178461A Pharmaceutical compositions comprising monoamine oxidase B inhibitors |
| 04/08/1998 | CN1178460A Use of compositions comprising stabilized biologically effective compounds |
| 04/08/1998 | CN1178458A Improvements in or relating to organic compositions |
| 04/08/1998 | CN1178220A Process for producing cefazolin |
| 04/08/1998 | CN1178219A Diterpene salicylate alkaloid, preparation and use thereof |
| 04/08/1998 | CN1178121A Injection for AIDs and preparation thereof |
| 04/08/1998 | CN1178119A Chinese medicinal preparation for senile dementia |
| 04/08/1998 | CN1178118A External use disinfectant anagesic and production thereof |
| 04/08/1998 | CN1178109A Medicine for burn and scald |
| 04/08/1998 | CN1037967C Novel intermediate and its use of preparation of acid |
| 04/08/1998 | CN1037966C Production of 4 -(5, 6, 7, 8 -tetrahydroimidazo £1.5-a| pyridine -5 -group) benzonitrile acidified hemihydrate |
| 04/08/1998 | CN1037934C Pharmaceutical soft capsules containing lysne elonixiwate |
| 04/08/1998 | CN1037932C Preparation of oral presentation forms for acid-unstable active compounds |
| 04/07/1998 | US5736582 Method and composition for controlled delivery of nascent oxygen from hydrogen peroxide source for skin treatment |
| 04/07/1998 | US5736581 Polyglycerol polyricinoleates |
| 04/07/1998 | US5736578 Treatment of sleep disorders |
| 04/07/1998 | US5736577 Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
| 04/07/1998 | US5736576 Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity |
| 04/07/1998 | US5736575 Administering theanine (l-glutamic acid-gamma-ethylamide) to a mammal; stimulants |
| 04/07/1998 | US5736574 Comprising a hydrolipid and at least one glyceryl monoalkyl ether |